GlassScriptPhysician profile
Carol J Butler
NPI 1831139666
$1,597.99
in general payments reported to CMS, 2019-2025
18 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $66.08 · 2021: $204 · 2022: $345 · 2023: $406 · 2024: $257 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $386.72 | 2023-2025 | Azstarys |
| Tris Pharma INC | $249.70 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $194.68 | 2020-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $186.64 | 2021-2023 | Qelbree |
| Sanofi Pasteur INC. | $148.84 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $58.21 | 2021-2025 | M-M-R II, Gardasil 9, Vaxneuvance |
| Neos Therapeutics, LP | $52.73 | 2019-2025 | Adzenys Xr-Odt |
| Astrazeneca Pharmaceuticals LP | $47.87 | 2023-2024 | Flumist Quadrivalent |
| Adlon Therapeutics L.P. | $46.81 | 2020-2021 | |
| Pfizer INC. | $42.18 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.03 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $33.52 | 2022 | |
| Organon LLC | $25.74 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $21.97 | 2025 | Jornay Pm |
| Abbvie INC. | $19.63 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $16.45 | 2025 | Relexxii |
| Ironwood Pharmaceuticals, INC | $15.63 | 2024 | |
| Shire North American Group INC | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.